Huaxia Eye Hospital Group Co Ltd
SZSE:301267
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.14
39.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Huaxia Eye Hospital Group Co Ltd
Cash & Cash Equivalents
Huaxia Eye Hospital Group Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cash & Cash Equivalents
¥3.9B
|
CAGR 3-Years
98%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cash & Cash Equivalents
¥853.8m
|
CAGR 3-Years
30%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cash & Cash Equivalents
¥5.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
24%
|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cash & Cash Equivalents
¥449.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cash & Cash Equivalents
¥667.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cash & Cash Equivalents
¥822.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Huaxia Eye Hospital Group Co Ltd
Glance View
Huaxia Eye Hospital Group Co., Ltd. engages in the provision of ophthalmology specialist medical services. The company is headquartered in Xiamen, Fujian and currently employs 6,653 full-time employees. The company went IPO on 2022-11-07. The firm's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The firm is also engaged in glasses and pharmacy retail business. The firm mainly conducts its business in the domestic market.
See Also
What is Huaxia Eye Hospital Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.9B
CNY
Based on the financial report for Dec 31, 2023, Huaxia Eye Hospital Group Co Ltd's Cash & Cash Equivalents amounts to 3.9B CNY.
What is Huaxia Eye Hospital Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
98%
Over the last year, the Cash & Cash Equivalents growth was 192%. The average annual Cash & Cash Equivalents growth rates for Huaxia Eye Hospital Group Co Ltd have been 98% over the past three years .
You don't have any saved screeners yet
